Fingerprint
Dive into the research topics of 'Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Selective growth inhibition in BRAF mutant thyroid cancer by the mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244
Douglas W. Ball, Ning Jin, D. Marc Rosen, Alan Dackiw, David Sidransky, Mingzhao Xing, Barry D. Nelkin
Research output: Contribution to journal › Article › peer-review
87
Scopus
citations